An Exploration of Oncology Professions Beyond Research and Clinical Practice
This session will provide insight into non-traditional professions within the oncology professional spectrum and provide learners with an opportunity to hear from successful examples of oncologists in these arenas.
Category
Format
  • Recorded Webcast
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
Recorded Presentations from the NCCN 2023 Annual Conference
The NCCN 2023 Annual Conference included educational sessions that highlight significant updates and key issues for select NCCN Guidelines®, new and emerging therapies, controversies in oncology care, issues affecting oncology care, and strategies to address barriers to practice.
Category
Format
Credits
Management of Recurrent or Metastatic Cervical Cancer
The systemic therapy section of the NCCN Guidelines for Cervical Cancer has continuously added new therapy options over the past few years to reflect the new approvals. Knowledge in this topic will guide the practitioners in appropriately prioritizing these new treatment options to further improve patient outcomes.
Category
  • Cervical Cancer
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma
Clinicians should be aware of the data supporting the use of immune checkpoint inhibitors, including nivolumab, in patients with various presentations of esophageal or esophagogastric junction cancers to identify the patients most likely to benefit from this treatment strategy.
Category
  • Gastric/Esophageal Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Radiation Therapy for Metastatic Brain Tumors
Whole-brain radiation therapy was historically the mainstay of treatment for brain metastases but has fallen out of favor in clinical practice over the last several decades. Strategies to promote cognitive preservation in patients with brain metastases is an area of active investigation. Clinicians need to remain up to date on these strategies.
Category
  • Central Nervous System Cancers
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Hereditary/Familial Ovarian Cancer: Testing Principles and Risk Management
Studies suggest a benefit of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk in carriers of a BRCA1/2 pathogenic/likely pathogenic (P/LP) variant, but the magnitude of the effect is not well-understood, and evidence is mixed regarding age at which RRSO should be undertaken and the specific P/LP variant (BRCA1 vs. BRCA2) carried. More data are needed regarding the efficacy of salpingectomy without oophorectomy in reducing the risk for ovarian cancer in carriers of a BRCA1/2 P/LP variant.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Management of Relapsed/Refractory Multiple Myeloma
Understanding optimal sequencing for patients with relapsed/refractory multiple myeloma can be a challenge in clinical practice. A uniform treatment approach cannot be applied to all patients. Physicians and other care providers must understand the evolving therapeutic options in the context of the patient's therapeutic and disease history to navigate through the complex treatment landscape.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Management of Metastatic Prostate Cancer
Clinicians need to be educated on results of recent trials and on updates to the NCCN Guidelines for Prostate Cancer recommendations so that they can provide optimal disease management for patients with metastatic prostate cancer.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Updates on the Management of Immunotherapy-Related Toxicities
As the field of cancer immunotherapy continues to evolve, clinicians need to be informed about the most up-to-date strategies for managing immunotherapy-related toxicities. Providing continuing education on early recognition and effective management of immunotherapy-related toxicities is crucial to ensure optimal outcomes for an increasing number of patients treated with immunotherapy.
Category
  • Management of Immunotherapy-Related Toxicities
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Plenary Session: Health System Recruitment and Retention Strategies
The staffing challenges cancer centers are experiencing as a result of the pandemic are unprecedented. Cancer centers may need to develop new strategies to improve staff recruitment and retention in today’s environment.
Category
Format
  • Recorded Webcast
Credits
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation

Pages